利气化瘀汤加减治疗儿童支气管哮喘30例临床观察  

Clinical Efficacy of Li-qi Hua-yu Decoction on Bronchial Asthma in Children: A Clinical Observation of 30 Cases

作　　者：谭丽珍[1] 刘德新[1] 钟文强[1] 邢可[1] 王娟[1] 

机构地区：[1]柳州市中医院,广西柳州545001

出　　处：《中医药导报》2013年第11期16-18,共3页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：广西中管局中医药民族医药传承研究项目(GZCC-16)

摘　　要：目的:观察利气化瘀汤治疗儿童支气管哮喘的临床疗效。方法:将符合诊断标准的60例轻中度支气管哮喘(急性发作期及慢性持续期)患儿随机分为治疗组和对照组各30例,治疗组予以张彩玲利气化瘀汤加减口服,对照组予布地奈德粉吸入剂治疗,急性发作期喘息明显者两组均加用β2受体激动剂口服。结果:治疗组总有效率为96.7%,对照组总有效率为83.3%;两组临床疗效比较,差异无统计学意义(P>0.05)。两组治疗1个月后嗜酸性粒细胞水平比较,治疗组低于对照组,差异有统计学意义(P<0.05)。结论:利气化瘀汤治疗儿童轻中度支气管哮喘有较好临床疗效。Objective： To evaluate the efficacy of Li-qi Hua-yu Decoction on bronchial asthma in children. Methods： The sixty patients with asthma fulfilling the criteria were enrolled into study. Patients were randomly allocated to treatment and control groups, 30 cases in each group. Patients were treated with Li-qi Hua-yu Decoction in treatment group, and Budesonide powder for inhalation in the control group. 132-agonist was given in two groups if necessary. Results： The total effective rate was 96.7% and 83.3% respectively in treatment and control groups, and the effect in the treatment group was better than that in control group, without significant difference （P〉0.05）. Peripheral-blood EOS counting in treatment group was higher than that of control group, and the difference was obviously significant （P〈0.01）. Conclusion： Li-qi Hua-yu Decoction can provide good effect for mild or moderate degree bronchial asthma in children.

关 键 词：利气化瘀汤 儿童 支气管哮喘 临床观察 

分 类 号：R272[医药卫生—中医儿科学]